Ultrasound Attenuation
Quantitative measurement of ultrasound signal loss through hepatic tissue to estimate liver steatosis alongside elastography.
If you have had a FibroScan, you usually get two numbers back: a stiffness score in kPa (scarring) and a CAP score in dB/m (liver fat). Fatty liver tissue absorbs sound waves faster than lean liver tissue, and ultrasound attenuation measures that exact drop-off. A CAP reading at or above 288 dB/m or a UGAP reading above 0.63 dB/cm/MHz points to elevated liver fat, giving you a concrete number you can track over time as you work on nutrition, weight, or MASH treatment.
What Is Ultrasound Attenuation?
- Attenuation is a quantitative ultrasound technique that measures the reduction in ultrasound signal amplitude as it passes through liver tissue, providing an estimate of hepatic steatosis1,2
How Is It Performed?
- Attenuation is measured by analyzing the attenuation of ultrasound waves as they pass through liver tissue2
- As liver fat (steatosis) increases, ultrasound waves are more strongly attenuated1
Use in MASLD/MASH Care
- Clinical guidelines recommend quantitative liver fat assessment (eg, CAP™ by FibroScan®) in the broader evaluation of MASLD/MASH3,4
- Attenuation (eg, CAP™) can be measured as part of an elastography exam (eg, VCTE™) for dual assessment of steatosis and fibrosis to support MASLD risk stratification and guide treatment decisions5
Strengths
- Noninvasive quantifiable estimate of liver fat1
- Good diagnostic accuracy with established cutoffs, sensitivity, and specificity1,6
- Attenuation (eg, CAP™) has been used to monitor change in liver fat in a MASH trial7
Limitations
- Measurement scale/output can vary across the various imaging platforms8
- Accuracy can be affected by technical factors such as transducer frequency and gain settings9
Published Cutoff Values Suggestive of Elevated Liver Fat
| Parameter | Cutoff | Sensitivity,a,b % | Specificity,a,c % |
|---|---|---|---|
| CAP™3,4 | ≥288 dB/m | 75% | 77% |
| UGAP4 | >0.63 dB/cm/MHz | 80% | 91% |